With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the “Retrievable Era” using TAVR products
- Saturday, June 26, 2021, 7:18
- PR Newswire
- Add a comment
SUZHOU, China, June 26, 2021 /PRNewswire/ — The TaurusElite® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusElite®”) developed by Peijia Medical (9996. HK) is approved for marketing by the National Medical Products Administration (NMPA) in June 2021 (Reg….
About the Author
admin has written 21717 stories on this site.